Wu J - Search Results

1

Landscape of tumor suppressor long noncoding RNAs in breast cancer.

Pang B, Wang Q, Ning S, Wu J, Zhang X, Chen Y, Xu S. Pang B, et al. Among authors: wu j. J Exp Clin Cancer Res. 2019 Feb 14;38(1):79. doi: 10.1186/s13046-019-1096-0. J Exp Clin Cancer Res. 2019. PMID: 30764831 Free PMC article.

2

Upregulation of DLEU1 expression by epigenetic modification promotes tumorigenesis in human cancer.

Pang B, Sui S, Wang Q, Wu J, Yin Y, Xu S. Pang B, et al. Among authors: wu j. J Cell Physiol. 2019 Aug;234(10):17420-17432. doi: 10.1002/jcp.28364. Epub 2019 Feb 21. J Cell Physiol. 2019. PMID: 30793303

3

Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.

Wu J, Lv Q, Huang H, Zhu M, Meng D. Wu J, et al. Genet Test Mol Biomarkers. 2020 Aug;24(8):484-491. doi: 10.1089/gtmb.2020.0047. Epub 2020 Jun 27. Genet Test Mol Biomarkers. 2020. PMID: 32598242

4

Identification of a Risk Predictive Signature Based on Genes Associated with Tumor Size and Lymph Node Involvement in Breast Cancer.

Wu J, Liu Y, Huang H, Zhu M, Zhang X. Wu J, et al. Genet Test Mol Biomarkers. 2022 Nov;26(11):532-542. doi: 10.1089/gtmb.2022.0124. Epub 2022 Nov 16. Genet Test Mol Biomarkers. 2022. PMID: 36383118

5

Effects of FGFR1 Gene Polymorphisms on the Risk of Breast Cancer and FGFR1 Protein Expression.

Wu J, Wang Y, Liu J, Chen Q, Pang D, Jiang Y. Wu J, et al. Cell Physiol Biochem. 2018;47(6):2569-2578. doi: 10.1159/000491653. Epub 2018 Jul 11. Cell Physiol Biochem. 2018. PMID: 29996114 Free article. Clinical Trial.

6

Identification of a four-long non-coding RNA signature in predicting breast cancer survival.

Zhu M, Lv Q, Huang H, Sun C, Pang D, Wu J. Zhu M, et al. Among authors: wu j. Oncol Lett. 2020 Jan;19(1):221-228. doi: 10.3892/ol.2019.11063. Epub 2019 Nov 7. Oncol Lett. 2020. PMID: 31897133 Free PMC article.

7

Identification of Hub Genes in Anaplastic Thyroid Carcinoma: Evidence From Bioinformatics Analysis.

Li L, Zhu M, Huang H, Wu J, Meng D. Li L, et al. Among authors: wu j. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820962135. doi: 10.1177/1533033820962135. Technol Cancer Res Treat. 2020. PMID: 33025856 Free PMC article.

8

Identification of Hub Genes and Pathways of Triple Negative Breast Cancer by Expression Profiles Analysis.

Li L, Huang H, Zhu M, Wu J. Li L, et al. Among authors: wu j. Cancer Manag Res. 2021 Mar 1;13:2095-2104. doi: 10.2147/CMAR.S295951. eCollection 2021. Cancer Manag Res. 2021. PMID: 33688252 Free PMC article.

9

FGFR1 Is Associated With Tamoxifen Resistance and Poor Prognosis of ER-Positive Breast Cancers by Suppressing ER Protein Expression.

Lv Q, Guan S, Zhu M, Huang H, Wu J, Dai X. Lv Q, et al. Among authors: wu j. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211004935. doi: 10.1177/15330338211004935. Technol Cancer Res Treat. 2021. PMID: 33783288 Free PMC article.

10

Identification of Potential Key Genes and Pathways for Inflammatory Breast Cancer Based on GEO and TCGA Databases.

Lv Q, Liu Y, Huang H, Zhu M, Wu J, Meng D. Lv Q, et al. Among authors: wu j. Onco Targets Ther. 2020 Jun 12;13:5541-5550. doi: 10.2147/OTT.S255300. eCollection 2020. Onco Targets Ther. 2020. PMID: 32606769 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77,715 results

Search Page

Filters